---
schema_version: "secwatch.filing_event.v1"
accession: "0001005286-24-000093"
form_type: "8-K"
ticker: "LFCR"
cik: "0001005286"
company_name: "LIFECORE BIOMEDICAL, INC. DE"
filed_at: "2024-07-24T23:59:59+00:00"
generated_at: "2026-05-31T16:36:53.563043+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Lifecore Biomedical approves FY2025 Annual Incentive Plan with EBITDA-based bonuses

## Summary
- CEO Paul Josephs target bonus 100% of base salary; CFO John D. Morberg 60%.
- Plan weighted 80% on Adjusted EBITDA and 20% on four business objectives.
- Maximum payout capped at 200% of target; minimum EBITDA threshold required.
- Clawback provision under Compensation Recoupment Policy applies to all payments.

## SEC filing metadata
- accession: 0001005286-24-000093
- form_type: 8-K
- ticker: LFCR
- cik: 0001005286
- company_name: LIFECORE BIOMEDICAL, INC. DE
- filed_at: 2024-07-24T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1005286/000100528624000093/0001005286-24-000093-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1005286/000100528624000093/lndc-20240718.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001005286-24-000093
- JSON: https://secwatch.observer/filing/0001005286-24-000093.json
- Plain text: https://secwatch.observer/filing/0001005286-24-000093.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.